Trial Profile
Measurement of Human T-Cell Turnover Following Vaccination With the Tuberculosis Vaccine MVA85A
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- 20 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2009 Planned end date changed from 1 Jul 2009 to 1 Feb 2010 as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.